Innoviva, Inc.
Innoviva, Inc. (INVA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · INVA · as of Mar 31, 2025
Ownership Breakdown
248
Institutional Holders
▲ 8 vs Q4
$1.24B
Total Inst. Value
▲ $4.57M vs Q4
73.81M
Shares Outstanding
freeFloat 93.58%
67.92M
13F Shares Held
▼ 3.29M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
INVA largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. pharmaceutical preparations | 9.21M | 14.69% | 14.69% | $167.06B | May 2, 2025 | ▼ 309.6K |
VANGUARD GROUP INC pharmaceutical preparations | 6.30M | 10.04% | 10.04% | $114.19B | May 9, 2025 | ▼ 14.0K |
DIMENSIONAL FUND ADVISORS LP pharmaceutical preparations | 4.66M | 7.43% | 7.43% | $84.48B | May 13, 2025 | ▼ 259.7K |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 4.56M | 7.27% | 7.27% | $82.62B | May 14, 2025 | ▲ 295.5K |
FRANKLIN RESOURCES INC pharmaceutical preparations | 3.97M | 6.33% | 6.33% | $71.98B | May 13, 2025 | ▼ 462.4K |
SARISSA CAPITAL MANAGEMENT LP pharmaceutical preparations | 2.82M | 4.49% | 4.49% | $51.05B | May 15, 2025 | ▼ 4.46M |
STATE STREET CORP pharmaceutical preparations | 2.36M | 3.77% | 3.77% | $42.86B | May 15, 2025 | ▼ 94.9K |
SYSTEMATIC FINANCIAL MANAGEMENT LP pharmaceutical preparations | 2.07M | 3.30% | 3.30% | $37.55B | May 14, 2025 | ▲ 42.2K |
MILLENNIUM MANAGEMENT LLC pharmaceutical preparations | 1.68M | 2.67% | 2.67% | $30.39B | May 15, 2025 | ▲ 1.28M |
AMERICAN CENTURY COMPANIES INC pharmaceutical preparations | 1.68M | 2.67% | 2.67% | $30.38B | May 13, 2025 | ▲ 251.4K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
26
Increased
+5.77M shares1
New Positions
first time holders22
Decreased
−9.12M shares0
Sold Out
fully exitedNet shares change (top 50)
3.35M
+5.77M / −9.12M
Net new holders
+5
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
INVA insider trading · insider activity
Source: SEC Form 4
19
Buy transactions
3
Sell transactions
6.33
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Basso Stephen Chief Financial Officer | May 15, 2026 | Award | 1,123 | — | — | 89.1K | Form 4 ↗ |
Basso Stephen Chief Financial Officer | May 20, 2026 | Tax Withhold | 559 | $22.24 | $12.4K | 88.6K | Form 4 ↗ |
Raifeld Pavel Chief Executive Officer | May 15, 2026 | Award | 1,123 | — | — | 287.1K | Form 4 ↗ |
Raifeld Pavel Chief Executive Officer | May 20, 2026 | Tax Withhold | 1,130 | $22.24 | $25.1K | 285.9K | Form 4 ↗ |
Zhen Marianne Chief Accounting Officer | May 20, 2026 | Tax Withhold | 1,127 | $22.24 | $25.1K | 57.5K | Form 4 ↗ |
Linden Josephine director | May 18, 2026 | Award | 9,461 | — | — | 15.2K | Form 4 ↗ |
Linden Josephine director | May 18, 2026 | Award | 9,166 | $21.80 | $199.8K | 9.2K | Form 4 ↗ |
Linden Josephine director | May 18, 2026 | Award | 5,733 | — | — | 5.7K | Form 4 ↗ |
Raifeld Pavel Chief Executive Officer | May 4, 2026 | Award | 312,500 | $22.99 | $7.18M | 312.5K | Form 4 ↗ |
Raifeld Pavel Chief Executive Officer | May 4, 2026 | Award | 126,646 | — | — | 285.9K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Innoviva, Inc. (INVA) is primarily owned by institutional investors, who hold approximately 92.0% of total shares outstanding. Company insiders own approximately 6.42%, while retail and public investors account for the remaining 1.56%.
The largest institutional shareholder of Innoviva, Inc. is BLACKROCK, INC., holding approximately 9.21 million shares — equal to 14.69% of outstanding shares — as of March 31, 2025.
A total of 248 institutional investors currently hold INVA stock, with a combined institutional value of approximately $1.24 billion as of the most recent 13F filing period.
Frequently asked questions
INVA ownershipInnoviva, Inc. (INVA) is primarily owned by institutional investors, who hold approximately 92.0% of shares. The largest shareholder is BLACKROCK, INC. with a 14.69% stake. Company insiders hold 6.42%. Data sourced from SEC Form 13F as of March 31, 2025.